BioMarin Pharma (BMRN) Tops Q3 EPS by 15c, Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/13/2026
- S&P 500 flat as chipmakers fall and bank earnings roll in
- Oil prices mixed as US-Russia diesel deal hopes offset Saudi Yemen attacks
- JPMorgan shares edge lower after third-quarter FICC revenue miss
- Fed’s Waller says US bond yield rise driven by growth, not inflation
- Wells Fargo beats profit estimates despite revenue miss
| BioMarin Pharmaceuticals, Inc. (NASDAQ: BMRN) | Delayed: 54.16 -1.23 (2.22%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $55.39 | 52 Week High | $108.96 | |||
| Open | $55.30 | 52 Week Low | $62.12 | |||
| Day High | $55.66 | P/E | N/A | |||
| Day Low | $53.93 | EPS | $-1.27 | |||
| Volume | 1,208,052 | |||||
